Ovarian primordial and nongrowing follicle counts according to the Stages of Reproductive Aging Workshop (STRAW) staging system

Menopause

Volumn 19, Issue 2, 2012, Pages 164-171

  Hansen, Karl R ^a   Craig, Latasha B ^a   Zavy, Michael T ^a   Klein, Nancy A ^b   Soules, Michael R ^b  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b Seattle Reproductive Medicine   (United States)

Author keywords

Menopause; Primordial follicles; Reproductive aging; Transition

Indexed keywords

ESTRADIOL; FOLLITROPIN; INHIBIN B; MUELLERIAN INHIBITING FACTOR;

ADULT; ARTICLE; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; FEMALE; FEMALE GENITAL TRACT PARAMETERS; FOLLITROPIN BLOOD LEVEL; FRACTIONATION; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; OVARIECTOMY; OVARY FOLLICLE; POST HOC ANALYSIS; QUESTIONNAIRE; STAGE OF REPRODUCTIVE AGING WORKSHOP STAGING SYSTEM; TRANSVAGINAL ECHOGRAPHY;

ADULT; AGING; ANTI-MULLERIAN HORMONE; CONGRESSES AS TOPIC; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; INHIBINS; MENSTRUAL CYCLE; MIDDLE AGED; OVARIAN FOLLICLE; OVARIECTOMY; REPRODUCTION;

EID: 84856540753     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/gme.0b013e31823b0b2e     Document Type: Article

References (37)

1. Soules MR, Sherman S, Parrott E, et al. Executive summary: Stages of Reproductive Aging Workshop (STRAW). Fertil Steril 2001;76: 874-878. (Pubitemid 33031310)
2. Sherman S. Defining the menopausal transition. Am J Med 2005;118:3s-7s. (Pubitemid 43083575)
3. Harlow SD, Mitchell ES, Crawford S, et al. The ReSTAGE Collaboration: defining optimal bleeding criteria for onset of early menopausal transition. Fertil Steril 2008;89:129-140.
4. Harlow SD, Cain K, Crawford S, et al. Evaluation of four proposed bleeding criteria for the onset of late menopausal transition. J Clin Endocrinol Metab 2006;91:3432-3438. (Pubitemid 44402115)
5. Taffe JR, Cain KC, Mitchell ES, et al. BPersistence[ improves the 60 days amenorrhea marker of entry to late stage menopausal transition for women aged 40-44. Menopause 2010;17:191-193.
6. Treloar AE, Boynton RE, Behn BG, et al. Variation of human menstrual cycle through reproductive life. Int J Fertil 1967;12:77-126.
7. Mitchell ES, Woods NF, Mariella A. Three stages of the menopausal transition from the Seattle Midlife Women's Health Study: toward a more precise definition. Menopause 2000;7:334-349.
8. Sowers MF, Crawford S, Sternfeld B, et al. Design, survey sampling and recruitment methods of SWAN: a multi-center, multi-ethnic, communitybased cohort study of women and the menopausal transition. In: Wren J, Lobo RA, Kelsey J, Marcus R, eds. Menopause: Biology and Pathobiology. San Diego, CA: Academic Press, 2000:175-188.
9. Taffe J, Dennerstein L, MacLennan A. Menstrual diary data and the menopausal transition: methodological issues. Acta Obstet Gynecol Scand 2001;81:588-594.
10. Randolf JF, Crawford S, Dennerstein L, et al. The value of folliclestimulating hormone concentration and clinical findings as markers of the late menopausal transition. J Clin Endocrinol Metab 2006;91:3034-3040. (Pubitemid 44271752)
11. Hale GE, Zhao X, Hughes CL, Burger HG, Robertson DM, Fraser IS. Endocrine features of menstrual cycles in middle and late reproductive age and the menopausal transition classified according to The Staging of Reproductive Aging Workshop (STRAW) staging system. J Clin Endocrinol Metab 2007;92:3060-3067. (Pubitemid 47236371)
12. Yang YS, Hur MH, Kim SY, Oh KY. Correlation between sonographic and endocrine markers of ovarian aging as predictors for late menopausal transition. Menopause 2011;18:138-145.
13. Gracia CR, Sammel MD, Freeman EW, et al. Defining menopause status: creation of a new definition to identify the early changes of the menopausal transition. Menopause 2005;12:128-135. (Pubitemid 40464279)
14. te Velde ER, Pearson PL. The variability of female reproductive aging. Hum Reprod Update 2002;8:141-154.
15. Broekmans FJ, Soules MR, Fauser BC. Ovarian aging: mechanisms and clinical consequences. Endocrinol Rev 2009;30:465-493.
16. Lambalk CB, van Disseldorp J, de Koning CH, Broekmans FJ. Testing ovarian reserve to predict age at menopause. Maturitas 2009;63:280-291.
17. Gougeon A. The early stages of follicular growth. In: Trounson AO, Gosden RG, eds. Biology and Pathology of the Oocyte: Role in Fertility and Reproductive Medicine. Cambridge: Cambridge University Press, 2003:29-41.
18. Charleston JS, Hansen KR, Thyer AC, et al. Estimating human ovarian non-growing follicle numberVthe application of modern stereology techniques to an old problem. Hum Reprod 2007;22:2103-2110. (Pubitemid 47241854)
19. Hansen KR, Knowlton NS, Thyer AC, Charleston JS, Soules MR, Klein NA. A new model of reproductive aging: the decline in ovarian non-growing follicle number from birth to menopause. Hum Reprod 2008;23:699-708. (Pubitemid 351651214)
20. Gundersen JJ, Bagger TF, Bendtsen SM, et al. The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. APMIS 1988;96: 857-881.
21. Gougeon A. Regulation of ovarian follicular development in primates: facts and hypotheses. Endocr Rev 1996;17:121-155. (Pubitemid 26119956)
22. Atsma F, Bartelink ML, Grobbee DE, van der Schouw YT. Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis. Menopause 2006;13:265-279.
23. van Der Voort DJ, van der Weijer PH, Barentsen R. Early menopause: increased fracture risk at older age. Osteoporosis Int 2003;14:525-530. (Pubitemid 36919215)
24. Trichopoulos D, MacMahon B, Cole P. Menopause and breast cancer risk. J Natl Cancer Inst 1972;48:605-613.
25. MacMahon B. Risk factors for endometrial cancer. Gynecol Oncol 1974;2:122-129.
26. Richardson S, Senikas V, Nelson J. Follicular depletion during the menopausal transition: evidence for accelerated loss and ultimate exhaustion. J Clin Endocrinol Metab 1987;65:1231-1237. (Pubitemid 18026863)
27. Hansen KR, Hodnett GM, Knowlton N, Craig LB. Correlation of ovarian reserve tests with histologically determined primordial follicle number. Fertil Steril 2011;95:170-175.
28. Rosen MP, Sternfeld B, Schuh-Huerta SM, Reijo Pera RA, McCulloch CE, Cedars MI. Antral follicle count: absence of significant midlife decline. Fertil Steril 2010;94:2182-2185.
29. Scheffer GJ, Broekmans FJM, Dorland M, et al. Antral follicle counts by transvaginal ultrasonography are related to age in women with proven natural fertility. Fertil Steril 1999;72:845-851. (Pubitemid 29505448)
30. Van Rooij IA, Broekmans FJ, Scheffer GJ, et al. Serum antimüllerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study. Fertil Steril 2005;83: 979-987.
31. Sowers MR, Eyvazzadeh AD, McConnell D, et al. Anti-müllerian hormone and inhibin B in the definition of ovarian aging and the menopause transition. J Clin Endocrinol Metab 2008;93:3478-3483.
32. Van Rooij IA, Tonkelaar I, Broekmans FJ, et al. Anti-müllerian hormone is a promising predictor for the occurrence of the menopausal transition. Menopause 2004;11:601-606. (Pubitemid 40353222)
33. Hehenkamp WJ, Looman CW, Themmen AP, et al. Anti-müllerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation. J Clin Endocrinol Metab 2006;91:4057-4063. (Pubitemid 44536885)
34. Pache TD, Wladimiroff JW, de Jong FH, Hop WC, Fauser BCJM. Growth patterns of nondominant ovarian follicles during the normal menstrual cycle. Fertil Steril 1990;54:638-642. (Pubitemid 20350651)
35. Tehrani FR, Shakeri N, Solaymani-Dodaran M, Azizi F. Predicting age at menopause from serum antimüllerian hormone concentration. Menopause 2011;18:766-770.
36. Bean JA, Leeper JD, Wallace RB, Sherman BM, Jagger H. Variations in the reporting of menstrual histories. Am J Epidemiol 1979;109: 181-185. (Pubitemid 10201149)
37. Taffe J, Dennerstein L. Retrospective self-reporting compared with menstrual diary data prospectively kept during the menopausal transition. Climacteric 2000;3:183-191.